Phase IIa trial of dronabinol in patients with obstructive sleep apnoea

Trial Profile

Phase IIa trial of dronabinol in patients with obstructive sleep apnoea

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Aug 2015

At a glance

  • Drugs Dronabinol (Primary)
  • Indications Sleep apnoea syndrome
  • Focus Therapeutic Use
  • Sponsors Cortex Pharmaceuticals; RespireRx Pharmaceuticals
  • Most Recent Events

    • 21 Aug 2015 Primary endpoint "Apnea-hypopnea index" has been met according to a Cortex Pharmaceuticals media release.
    • 01 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top